Key Findings of the Comprehensive Care Visit

• Future course of therapy is based on two key findings:
  

  –	Labs determine the inhibitor titer to be 75 BU
  –	Joint deterioration and limited range of motion in both knees, leading to loss of muscle mass

• Based on these findings, a two-pronged management approach is recommended:
  

  –	Begin prophylactic therapy with a bypassing agent to minimize bleeding episodes
  –	Physical therapy to improve joint function

 

Cindy Leissinger, MD Professor of Medicine, Pediatrics & Pathology Chief, Section of Hematology & Medical Oncology Tulane University School of Medicine